0001144204-19-027766.txt : 20190522
0001144204-19-027766.hdr.sgml : 20190522
20190522171034
ACCESSION NUMBER: 0001144204-19-027766
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20090527
FILED AS OF DATE: 20190522
DATE AS OF CHANGE: 20190522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howell Stephen B.
CENTRAL INDEX KEY: 0001464306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 19846703
MAIL ADDRESS:
STREET 1: 2408 TIMBERLOCH PLACE, B-7
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3333 LEE PARKWAY
STREET 2: SUITE 600
CITY: DALLAS
STATE: TX
ZIP: 75219
BUSINESS PHONE: 2149055100
MAIL ADDRESS:
STREET 1: 3333 LEE PARKWAY
STREET 2: SUITE 600
CITY: DALLAS
STATE: TX
ZIP: 75219
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
tv522178_4.xml
OWNERSHIP DOCUMENT
X0306
4
2009-05-27
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001464306
Howell Stephen B.
1330 AVENUE OF THE AMERICAS
33RD FLOOR
NEW YORK
NY
10019
1
0
0
0
Common stock
2012-01-23
4
A
0
300
0
A
495
D
Common stock
2015-05-11
4
A
0
75000
0
A
75495
D
Stock Option (right to buy)
69
2009-05-27
4
A
0
500
0
A
2019-05-27
Common stock
500
500
D
Stock Option (right to buy)
69
2009-05-27
4
A
0
200
0
A
2019-05-27
Common stock
200
200
D
Stock Option (right to buy)
122.50
2010-05-26
4
A
0
600
0
A
2020-05-26
Common stock
600
600
D
Stock Option (right to buy)
113.50
2011-05-26
4
A
0
700
0
A
2021-05-26
Common stock
700
700
D
Stock Option (right to buy)
30.50
2012-05-24
4
A
0
700
0
A
2022-05-24
Common stock
700
700
D
Stock Option (right to buy)
11.50
2012-12-11
4
A
0
2000
0
A
2022-12-11
Common stock
2000
2000
D
Stock Option (right to buy)
18.50
2014-03-07
4
A
0
10000
0
A
2024-03-07
Common stock
10000
10000
D
Stock Option (right to buy)
7.34
2015-05-11
4
A
0
75000
0
A
2025-05-11
Common stock
75000
75000
D
Stock Option (right to buy)
2.31
2016-02-11
4
A
0
50000
0
A
2026-02-11
Common stock
50000
50000
D
Stock Option (right to buy)
4.45
2016-12-13
4
A
0
50000
0
A
2026-12-13
Common stock
50000
50000
D
Stock Option (right to buy)
16
2017-12-14
4
A
0
30000
0
A
2027-12-14
Common stock
30000
30000
D
The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014.
Vests 100% six months after grant date.
/s/ Neena M. Patil, as Attorney-in-fact
2019-05-22